Serum IL-6 levels are higher in patients with HCC compared with healthy controls, and elevated serum IL-6 levels are known to be a risk factor for the development of HCC in patients with chronic liver disease, independent of other risk factors such as hepatitis virus infection [16]. This evidence concerns the gene IL6 and hepatocellular carcinoma.